China To Step Up Supervision Of APIs And Drug Excipients – PDA-FDA Supply Chain Conference
This article was originally published in The Pink Sheet Daily
Executive Summary
China’s State FDA plans to launch a drug master file system and may integrate that system into existing regulations.